Trulieve Cannabis (TCNNF) Total Current Liabilities (2020 - 2026)
Trulieve Cannabis (TCNNF) recorded quarterly Total Current Liabilities of $124.2 million in Q1 2026, down 2.19% quarter-over-quarter from $126.9 million in Q4 2025, and down 9.15% on a YoY basis from $136.7 million in Q1 2025.
Trulieve Cannabis (TCNNF) Total Current Liabilities (2020 - 2026) Analysis & Trends
Trulieve Cannabis' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $124.2 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 9.15% year-over-year to $124.2 million; the TTM figure through Mar 2026 stood at $124.2 million (down 9.15% YoY), while the FY2025 annual figure was $126.9 million, down 8.34% from the prior year.
- Total Current Liabilities was $124.2 million for Q1 2026 at Trulieve Cannabis, down from $126.9 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $251.8 million in Q3 2023 to a low of $114.8 million in Q4 2023.
- Historically, Total Current Liabilities has averaged $159.5 million across 5 years, with a median of $136.7 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Total Current Liabilities soared 135.12% in 2022, then sank 48.54% in 2024.
- A 5-year view of Total Current Liabilities shows it stood at $210.3 million in 2022, then sank by 45.39% to $114.8 million in 2023, then advanced by 20.59% to $138.5 million in 2024, then retreated by 8.34% to $126.9 million in 2025, then fell by 2.19% to $124.2 million in 2026.
- The last three Total Current Liabilities figures came in at $124.2 million (Q1 2026), $126.9 million (Q4 2025), and $124.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | Trulieve Cannabis | - | - | 170.08 Mn | 124.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 124.16 Mn |
| Dec 31, 2025 | 126.95 Mn |
| Sep 30, 2025 | 124.13 Mn |
| Jun 30, 2025 | 123.84 Mn |
| Mar 31, 2025 | 136.67 Mn |
| Dec 31, 2024 | 138.49 Mn |
| Sep 30, 2024 | 136.69 Mn |
| Jun 30, 2024 | 123.80 Mn |
| Mar 31, 2024 | 117.19 Mn |
| Dec 31, 2023 | 114.85 Mn |
| Sep 30, 2023 | 251.77 Mn |
| Jun 30, 2023 | 240.59 Mn |
| Mar 31, 2023 | 188.27 Mn |
| Dec 31, 2022 | 210.30 Mn |
| Sep 30, 2022 | 150.28 Mn |
| Jun 30, 2022 | 165.37 Mn |
| Mar 31, 2022 | 237.80 Mn |
| Dec 31, 2021 | 168.94 Mn |
| Sep 30, 2021 | 94.47 Mn |
| Jun 30, 2021 | 77.45 Mn |